{
  "abstract": "Bacterial vaginosis (BV) affects one-in-four reproductive-aged women, is challenging to cure and is associated with preterm birth, miscarriage and increased risk of acquiring sexually transmitted infections (STIs) and HIV. 1 To date, global guidelines recommend treating only women with antibiotics, a strategy that results in recurrence rates over 50%,2 rising to 60–80% among women with ongoing male partners.2 3",
  "authors": [
    {
      "affiliations": [
        "School of Translational Medicine, Monash University, Carlton, Victoria, Australia",
        "Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia",
        "Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia"
      ],
      "name": "Catriona S Bradshaw"
    },
    {
      "affiliations": [
        "School of Translational Medicine, Monash University, Carlton, Victoria, Australia",
        "Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia",
        "Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia"
      ],
      "name": "Lenka A Vodstrcil"
    }
  ],
  "title": "Concurrent partner treatment to improve BV cure",
  "uid": "6a57df24-b287-5316-babc-fb66fb95db65"
}